Cardinal Capital Management Acquires 1,282 Shares of Sanofi (NASDAQ:SNY)

Cardinal Capital Management grew its holdings in shares of Sanofi (NASDAQ:SNY) by 1.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 68,805 shares of the company’s stock after purchasing an additional 1,282 shares during the quarter. Cardinal Capital Management’s holdings in Sanofi were worth $3,318,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of SNY. Jennison Associates LLC increased its position in Sanofi by 938.0% in the 3rd quarter. Jennison Associates LLC now owns 1,904,445 shares of the company’s stock valued at $109,753,000 after buying an additional 1,720,972 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of Sanofi by 28,890.2% during the third quarter. Thrivent Financial for Lutherans now owns 1,429,219 shares of the company’s stock valued at $82,366,000 after acquiring an additional 1,424,289 shares in the last quarter. DAVENPORT & Co LLC raised its position in shares of Sanofi by 40.7% during the fourth quarter. DAVENPORT & Co LLC now owns 2,295,569 shares of the company’s stock worth $110,715,000 after purchasing an additional 664,455 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of Sanofi by 20.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock worth $133,172,000 after purchasing an additional 399,301 shares in the last quarter. Finally, Franklin Resources Inc. grew its position in Sanofi by 13.1% in the 3rd quarter. Franklin Resources Inc. now owns 3,407,452 shares of the company’s stock valued at $208,106,000 after purchasing an additional 395,744 shares during the period. Institutional investors and hedge funds own 14.04% of the company’s stock.

Sanofi Stock Performance

Shares of SNY stock opened at $54.50 on Tuesday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.46 and a quick ratio of 0.74. The firm has a 50-day moving average of $50.42 and a 200-day moving average of $52.47. Sanofi has a one year low of $45.22 and a one year high of $58.97. The company has a market cap of $138.31 billion, a P/E ratio of 21.89, a P/E/G ratio of 0.99 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.58%. Equities research analysts forecast that Sanofi will post 4.36 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on SNY shares. StockNews.com downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Finally, Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.